Provided by Tiger Fintech (Singapore) Pte. Ltd.

Bio-Techne

57.09
+3.095.72%
Post-market: 57.090.00000.00%19:27 EDT
Volume:1.44M
Turnover:82.12M
Market Cap:8.95B
PE:124.11
High:57.43
Open:54.89
Low:54.31
Close:54.00
52wk High:80.95
52wk Low:46.01
Shares:156.77M
Float Shares:154.93M
Volume Ratio:0.93
T/O Rate:0.93%
Dividend:0.32
Dividend Rate:0.56%
EPS(TTM):0.4600
EPS(LYR):0.4660
ROE:3.68%
ROA:6.30%
PB:4.66
PE(LYR):122.52

Loading ...

Evercore ISI Adjusts Bio-Techne Price Target to $70 From $75, Maintains Outperform Rating

MT Newswires Live
·
Apr 02

BRIEF-Leica Biosystems And Bio-Techne Expand Partnership To Enable Protease-Free Workflows For Automated Spatial Multiomics On The BOND RX Research Staining Instrument

Reuters
·
Apr 02

Leica Biosystems and Bio-Techne Expand Partnership to Enable Protease-Free Workflows for Automated Spatial Multiomics on the BOND RX Research Staining Instrument

PR Newswire
·
Apr 02

Bio-Techne Corp. Stock Underperforms Tuesday When Compared To Competitors

Dow Jones
·
Apr 02

RBC Trims Price Target on Bio-Techne to $79 From $80, Maintains Sector Perform Rating

MT Newswires Live
·
Apr 01

Bio-Techne Opens New Customer Experience Centre in Germany

Zacks
·
Mar 31

Bio-Techne Corp. Stock Underperforms Friday When Compared To Competitors

Dow Jones
·
Mar 29

Research Tools & Consumables Stocks Q4 Earnings: Bio-Techne (NASDAQ:TECH) Best of the Bunch

StockStory
·
Mar 28

Bio-Techne to Open New Customer Facility in Germany

MT Newswires Live
·
Mar 26

Bio-Techne Announces New Customer Experience Centre in Düsseldorf, Germany

PR Newswire
·
Mar 26

Bio-Techne Corp. Stock Outperforms Competitors Despite Losses On The Day

Dow Jones
·
Mar 26

Bio-Techne to Highlight Advances in the Detection of Clinically Relevant Biomarkers using RNAscope Technologies at the 2025 USCAP Annual Meeting

PR Newswire
·
Mar 24

Bio-Techne Corp. Stock Underperforms Wednesday When Compared To Competitors

Dow Jones
·
Mar 20

Bio-Techne Initiated at Outperform by Evercore ISI Group

Dow Jones
·
Mar 18

Evercore ISI Initiates Bio-Techne at Outperform With $75 Price Target

MT Newswires Live
·
Mar 18

Bio-Techne initiated with an Outperform at Evercore ISI

TIPRANKS
·
Mar 18

Bio-Techne: A Premium Growth Asset with Strong Market Position and Promising Future

TIPRANKS
·
Mar 18

Q4 Rundown: PacBio (NASDAQ:PACB) Vs Other Life Sciences Tools & Services Stocks

StockStory
·
Mar 17

Bio-Techne Corp. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Mar 15

Bio-Techne Corp. Stock Underperforms Monday When Compared To Competitors

Dow Jones
·
Mar 11